Key result
Hypertension in type 2 diabetes is linked to ~3-fold higher rates of chronic heart failure.
Why the study?
The study was conducted to investigate the relationship between arterial hypertension and risk factors or subclinical target organ damage in patients with type 2 diabetes mellitus.
Does arterial hypertension increase the prevalence of target organ damage and cardiovascular risk factors in patients with type 2 diabetes mellitus?
Cross-Sectional (n=528)
No
Does arterial hypertension increase the prevalence of target organ damage and cardiovascular risk factors in patients with type 2 diabetes mellitus?
Arterial hypertension in patients with type 2 diabetes mellitus significantly increases the burden of macro- and microvascular target organ damage, underscoring the critical need for early risk factor screening.
Hypertension was associated with greater target organ damage in type 2 diabetes; hypothesis-generating and requires prospective confirmation before guiding care.
AIM: to investigate relationship between arterial hypertension (AH) and risk factors / subclinical damage of target organs in patients with type 2 diabetes mellitus (DM2). METHODS: We included into this clinical epidemiological study 528 patients with DM2 (30.5 % men, 69.5 % women; mean age 54.1±0.3 years; 80.3 % with AH, 19.7 % without AH), who answered questions of the ARIC study questionnaire related to risk factors. Also, we studied features of target organ damage and laboratory indicators. RESULTS: In comparison with normotensives patients with AH more frequently had ischemic heart disease (12.7±1.6 % vs. 5.8±2.3 %, p<0.05), chronic heart failure (CHF) (30.9±2.2 % vs. 9.6±2.9 %, p<0.001), atherosclerosis of vessels of lower extremities (69.8±2.2 % vs. 53.8±4.9 %, p<0.01) and cerebral vessels (50.9±2.4 % vs. 28.8±4.4 %, p<0.001), history of stroke (5.0±1.1 % vs. 0 %, p<0.05), hypertonic angiopathy (14.5±1.8 % vs. 6.5±2.5 %, p<0.05), low level of high density lipoprotein (87.3±2.2 % vs. 74.5±6.4 %, p<0.05), electro- and echocardiographic signs of left ventricular hypertrophy (75.6±2.1 % vs. 45.4±5.1 %, p<0.001; 61.1±2.6 % vs. 24.4±4.7 %, p<0.001, respectively), lowering of left ventricular ejection fraction (12.5±1.7 % vs. 7.8±2.8 %, p<0.001), diastolic disfunction of the left ventricle (52.6±2.7 % vs. 23.2±4.7 %, p<0.001), atherosclerosis of the aorta (38.0±2.6 % vs. 20.7±4.5 %, p<0.01), lowering of the ankle-brachial index (left - 29.8±2.3 % vs. 14.9±3.5 %, p<0.01; right - 31.5±2.3 % vs. 9.9±3.0 %, p<0.001, respectively), increased intima-media thickness of the right carotid artery (84.6±5.0 % vs. 60.0±11.0 %, p<0.05). CONCLUSION: In patients with type 2 diabetes and AH, in order to develop strategy of macro- and microvascular complications prevention, it is necessary to conduct early screening of risk factors and subclinical damage of target organs.
No takes yet. Share an insight, caveat, or question.
Mehdiyev et al. (2019) conducted a cross-sectional in Type 2 diabetes mellitus (n=528). Arterial hypertension vs. Normotension was evaluated on Chronic heart failure (CHF) (p=<0.001). In patients with type 2 diabetes, the presence of arterial hypertension was associated with significantly higher rates of target organ damage, including chronic heart failure (30.9% vs. 9.6%, p<0.001) and left ventricular hypertrophy (75.6% vs. 45.4%, p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: